Open AccessStrofantin and novazurol for heart disease
Author(s) -
L. I. Vilensky
Publication year - 2021
Publication title -
kazan medical journal
Language(s) - English
Resource type - Journals
eISSN - 2587-9359
pISSN - 0368-4814
DOI - 10.17816/kazmj77072
Subject(s) - digitalis , decompensation , strophanthin , medicine , cardiac decompensation , cardiology , heart disease , digitalis glycosides , heart failure , ouabain , chemistry , organic chemistry , sodium
Weiss (Deut, med Woch., 1924 No. 33) reports on his observations on the treatment of severe cardiac patients with strophanthin and novosurol. In chronic heart diseases in a state of sharp decompensation, sometimes digitalis has no effect, especially when the body, due to the prolonged use of small doses of digitalis, has become accustomed to this remedy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom